Effects on fertility: See also Precautions and Pharmacology: Pharmacodynamics under Actions.
Use in pregnancy: Category D.
The use of Androcur is contraindicated during pregnancy (also see Contraindications).
Administration of cyproterone acetate during the hormone-sensitive differentiation phase of the genital organs (after approx. day 45 of pregnancy) could lead to signs of feminisation in male fetuses.
Use in lactation: The use of Androcur is contraindicated during lactation as small amounts of cyproterone acetate are excreted in human milk (see Contraindications).